Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the side effects and best dose of efaproxiral when
given with carmustine and to see how well they work in treating patients with progressive or
recurrent malignant glioma.